Hematopoietic stem cell mobilization: updated conceptual renditions
- 6 September 2012
- journal article
- review article
- Published by Springer Nature in Leukemia
- Vol. 27 (1) , 24-31
Abstract
Despite its specific clinical relevance, the field of hematopoietic stem cell mobilization has received broad attention, owing mainly to the belief that pharmacologic stem cell mobilization might provide clues as to how stem cells are retained in their natural environment, the bone marrow ‘niche’. Inherent to this knowledge is also the desire to optimally engineer stem cells to interact with their target niche (such as after transplantation), or to lure malignant stem cells out of their protective niches (in order to kill them), and in general to decipher the niche’s structural components and its organization. Whereas, with the exception of the recent addition of CXCR4 antagonists to the armamentarium for mobilization of patients refractory to granulocyte colony-stimulating factor alone, clinical stem cell mobilization has not changed significantly over the last decade or so, much effort has been made trying to explain the complex mechanism(s) by which hematopoietic stem and progenitor cells leave the marrow. This brief review will report some of the more recent advances about mobilization, with an attempt to reconcile some of the seemingly inconsistent data in mobilization and to interject some commonalities among different mobilization regimes.Keywords
This publication has 106 references indexed in Scilit:
- Mobilization of hematopoietic stem and progenitor cells using inhibitors of CXCR4 and VLA-4Leukemia, 2011
- Osteopoietic engraftment after bone marrow transplantation: Effect of inbred strain of miceExperimental Hematology, 2010
- Mesenchymal and haematopoietic stem cells form a unique bone marrow nicheNature, 2010
- Novel insight into stem cell mobilization-Plasma sphingosine-1-phosphate is a major chemoattractant that directs the egress of hematopoietic stem progenitor cells from the bone marrow and its level in peripheral blood increases during mobilization due to activation of complement cascade/membrane attack complexLeukemia, 2010
- Fifth complement cascade protein (C5) cleavage fragments disrupt the SDF-1/CXCR4 axis: Further evidence that innate immunity orchestrates the mobilization of hematopoietic stem/progenitor cellsExperimental Hematology, 2010
- Mobilization studies in complement-deficient mice reveal that optimal AMD3100 mobilization of hematopoietic stem cells depends on complement cascade activation by AMD3100-stimulated granulocytesLeukemia, 2009
- Insights into the biology of mobilized hematopoietic stem/progenitor cells through innovative treatment schedules of the CXCR4 antagonist AMD3100Experimental Hematology, 2009
- Concurrent Blockade of α4-Integrin and CXCR4 in Hematopoietic Stem/Progenitor Cell MobilizationStem Cells, 2009
- Live-animal tracking of individual haematopoietic stem/progenitor cells in their nicheNature, 2008
- Transplantable marrow osteoprogenitors engraft in discrete saturable sites in the marrow microenvironmentExperimental Hematology, 2008